Literature DB >> 22934692

Antiangiogenic triterpenes isolated from Chinese herbal medicine Actinidia chinensis Planch.

Wen-Jun Zhu1, De-Hong Yu, Mei Zhao, Meng-Gan Lin, Qin Lu, Qi-Wei Wang, Ying-Yun Guan, Gui-Xiu Li, Xin Luan, Yi-Fang Yang, Xue-Mei Qin, Chao Fang, Guo-Hong Yang, Hong-Zhuan Chen.   

Abstract

Actinidia chinensis Planch. is a famous Chinese herbal medicine to treat many diseases such as cancers. Triterpenes, polyphenols and anthraquinones are normally considered as the main constituents for its effects. In this study, eleven known triterpenes were isolated from the root of Actinidia chinensis., and were examined for its antiangiogenic activities. Their structures were elucidated by comprehensive spectroscopic methods, including IR, UV, HR-ESI-MS, and 1D and 2D NMR techniques. The eleven compounds are following: 2α,3α,19-trihydroxyurs-12-en-28-oic acid (1), 2α,3β-dihydroxyurs-12-en-28-oic acid (2), 2α,3α,23-trihydroxyurs-12-en-28-oic acid (3), asiatic acid (4), ursolic acid (5), 2α,3β,19,24-tetrahydroxyurs-12-en-28-oic acid (6), 2α,3β,19-trihydroxyolean-12-en-28-oic acid (7), 2α,3α,24-trihydroxyolean-12-en-28-oic acid (8), oleanolic acid (9), 3β-O-acetyloleanolic acid (10), 2α,23-dihydroxylmicromeric acid (11). All these compounds were evaluated with respect to their antiangiogenic activities utilizing the assays of human umbilical vein endothelial cells (HUVEC) proliferation and tube formation and Ursolic acid (used as control) and compounds 2, 3, 4, and 8 exhibited significant, dose-dependently, antiangiogenic activity in the tested concentration range. Our findings suggest that antitumor action of Actinidia chinensis Planch. is partly via inhibiting tumor angiogenesis by triterpenes, and compounds 2, 3, 4, and 8 as the novel potential antiangiogenic agents are worthy of further translational research.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 22934692     DOI: 10.2174/1871520611313020002

Source DB:  PubMed          Journal:  Anticancer Agents Med Chem        ISSN: 1871-5206            Impact factor:   2.505


  8 in total

1.  Corosolic Acid Inhibits Hepatocellular Carcinoma Cell Migration by Targeting the VEGFR2/Src/FAK Pathway.

Authors:  Chung-Yu Ku; Ying-Ren Wang; Hsuan-Yuan Lin; Shao-Chun Lu; Jung-Yaw Lin
Journal:  PLoS One       Date:  2015-05-15       Impact factor: 3.240

2.  In Silico Studies Revealed Multiple Neurological Targets for the Antidepressant Molecule Ursolic Acid.

Authors:  Rajeev K Singla; Luciana Scotti; Ashok K Dubey
Journal:  Curr Neuropharmacol       Date:  2017-11-14       Impact factor: 7.363

3.  Actinidia chinensis Planch root extract inhibits cholesterol metabolism in hepatocellular carcinoma through upregulation of PCSK9.

Authors:  Mingyan He; Jiayun Hou; Lingyan Wang; Minghuan Zheng; Tingting Fang; Xiangdong Wang; Jinglin Xia
Journal:  Oncotarget       Date:  2017-06-27

4.  Combination of Astragali Polysaccharide and Curcumin Improves the Morphological Structure of Tumor Vessels and Induces Tumor Vascular Normalization to Inhibit the Growth of Hepatocellular Carcinoma.

Authors:  Decai Tang; Shuo Zhang; Xiaoxia Shi; Jiafei Wu; Gang Yin; Xiying Tan; Fuyan Liu; Xingdong Wu; Xiangyu Du
Journal:  Integr Cancer Ther       Date:  2019 Jan-Dec       Impact factor: 3.279

Review 5.  Actinidia chinensis Planch.: A Review of Chemistry and Pharmacology.

Authors:  Xirui He; Jiacheng Fang; Xufei Chen; Zefeng Zhao; Yongsheng Li; Yibing Meng; Linhong Huang
Journal:  Front Pharmacol       Date:  2019-10-30       Impact factor: 5.810

6.  Actinidia chinensis Planch Root extract suppresses the growth and metastasis of hypopharyngeal carcinoma by inhibiting E2F Transcription Factor 1-mediated MNX1 antisense RNA 1.

Authors:  Yi Zheng; Lizhong Su; Jun Tan; Feilin Dong
Journal:  Bioengineered       Date:  2022-03       Impact factor: 3.269

7.  Teng-Long-Bu-Zhong-Tang, a Chinese herbal formula, enhances anticancer effects of 5--Fluorouracil in CT26 colon carcinoma.

Authors:  Shan Deng; Bing Hu; Hong-Mei An; Qin Du; Ling Xu; Ke-Ping Shen; Xiu-Feng Shi; Meng-Meng Wei; Yang Wu
Journal:  BMC Complement Altern Med       Date:  2013-06-08       Impact factor: 3.659

8.  Corosolic Acid Inhibits Cancer Progress Through Inactivating YAP in Hepatocellular Carcinoma.

Authors:  Ming Jia; Yulin Xiong; Maoshi Li; Qing Mao
Journal:  Oncol Res       Date:  2020-03-27       Impact factor: 5.574

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.